Position in GILD
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$1,057,086
-$28,745 QoQ
Shares Held
8,367
+7.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,044
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $209,939,553 across 14 Drug Manufacturers - General names. GILD ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
130,247 | $156,222,172 | |
| 2 | JNJ |
Johnson & Johnson
|
62,574 | $15,891,918 | |
| 3 | ABBV |
AbbVie Inc.
|
47,980 | $12,073,687 | |
| 4 | MRK |
Merck & Co., Inc.
|
54,116 | $6,953,906 | |
| 5 | AMGN |
Amgen Inc
|
17,375 | $6,291,835 | |
| 6 | PFE |
Pfizer Inc
|
169,378 | $4,078,622 | |
| 7 | AZN |
Astrazeneca PLC
|
9,817 | $1,861,499 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,784 | $1,716,154 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,057,086 | 8,367 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $1,085,831 | 7,791 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,624,341 | 13,234 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,457,097 | 13,127 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,472,131 | 13,278 | Shares | Sole | 2025-09-12 | |
| 2025-03-31 | $1,172,827 | 10,467 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $885,274 | 9,584 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $799,749 | 9,539 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $581,058 | 8,469 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $641,889 | 8,763 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $596,476 | 7,363 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $514,987 | 6,872 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $682,146 | 8,851 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $678,445 | 8,177 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $613,484 | 7,146 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $263,601 | 4,273 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $258,365 | 4,180 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $466,623 | 7,849 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $556,192 | 7,660 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $505,294 | 7,234 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $426,656 | 6,196 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $257,421 | 3,983 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $147,747 | 2,536 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $226,157 | 3,579 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $421,400 | 5,477 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $316,683 | 4,236 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||